Stock 4506 SUMITOMO PHARMA CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Sumitomo Pharma Co., Ltd.

Equities

4506

JP3495000006

Delayed Japan Exchange
Other stock markets
 11:42:03 2024-05-16 pm EDT 		5-day change 1st Jan Change
336 JPY -5.35% Intraday chart for Sumitomo Pharma Co., Ltd. -17.44% -27.90%
May. 09 Sumitomo Pharma Co., Ltd. agreed to acquire MELTz Business of MELTIN MMI Co., Ltd. CI
May. 07 Profit-Taking, China Outlooks Churn Asian Stock Markets MT

Evolution of the average Target Price on Sumitomo Pharma Co., Ltd.

Price target over the last 5 years

History of analyst recommendation changes

101670.xbr9xXeh_sX7ReleHYp60NG_mkrayJ0LdnhS0XIlitk.t9aFoh7yi66RP7s9WuBIgIvptxyri9NMNyIIkApo0IiS6IfzJZeQk6t9ig~68b91a6ec4e5ccab98162ab37c5b5513

Analyst Recommendations on Sumitomo Pharma Co., Ltd.

Jefferies Adjusts Sumitomo Pharma’s Price Target to 420 Yen From 520 Yen, Keeps at Hold MT
Japan's Nikkei slips after Fed chair signals delay in rate cut RE
Interest Rates, China Housing Measures Lift Asian Stock Markets MT
Japanese Shares End Higher on Tuesday After BOJ Kept Rate Unchanged; Shares of Nippon Electric Glass Jump Over 10% MT
Jefferies Adjusts Sumitomo Pharma’s Price Target to 520 Yen From 700 Yen, Keeps at Hold MT
Japan's Nikkei tracks Wall Street lower on Fed rate hike bets RE
Jefferies Downgrades Sumimoto Pharma to Hold From Buy, Adjusts Price Target to 700 Yen From 1,050 Yen MT
Jefferies Upgrades Sumitomo Pharma to Buy From Hold, Adjusts Price Target to 1,050 Yen From 830 Yen MT
Jefferies Adjusts Sumitomo Pharma's Price Target to 830 Yen From 950 Yen, Keeps at Hold MT
Nikkei 225 Down 1.1% on Inflation, Interest Rate Outlooks MT
Nikkei 225 : Slips 0.2% on Profit-Taking, Rising Interest Rates MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
8
Last Close Price
355 JPY
Average target price
333.8 JPY
Spread / Average Target
-5.99%
High Price Target
420 JPY
Spread / Highest target
+18.31%
Low Price Target
250 JPY
Spread / Lowest Target
-29.58%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Sumitomo Pharma Co., Ltd.

Jefferies & Co.

Ratings for Sumitomo Pharma Co., Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. 4506 Stock
  4. Consensus Sumitomo Pharma Co., Ltd.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW